Meeting
2021 ASCO Annual Meeting
Stereotactic body radiation therapy and in situ oncolytic virus therapy followed by immunotherapy in metastatic non-small cell lung cancer.
Authors
Carlo Guerrero
Houston Methodist Hospital, Houston, TX
Carlo Guerrero , Joe E. Ensor Jr., Kai Sun , Andrew M. Farach , Sindhu Nair , Jun Zhang , Monisha Singh , Jorge German Darcourt , Priya V. Ramshesh , Edward Brian Butler , Bin S. Teh , Mark Sultenfuss , Nakul Gupta , Helen E. Heslop , Jaime A. Mejia , Jenny Chee Ning Chang , Eric Bernicker
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Metastatic
Track
Lung Cancer
Sub Track
Metastatic Non–Small Cell Lung Cancer
Clinical Trial Registration Number
NCT03004183
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 9115)
DOI
10.1200/JCO.2021.39.15_suppl.9115
Abstract #
9115
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2018 ASCO-SITC Clinical Immuno-Oncology Symposium
Efficacy of immune-checkpoint inhibitors (ICI) in non-small cell lung cancer (NSCLC) patients harboring activating molecular alterations.
First Author: Laurent Mhanna
Poster
2024 ASCO Breakthrough
Efficacy and safety of surufatinib plus toripalimab in previously treated advanced tumors progressing after immunotherapy.
First Author: Panpan Zhang
First Author: Jeddeo Paul
Poster
2024 ASCO Genitourinary Cancers Symposium
Preclinical testing of a novel PD-L1 inhibitor for the treatment of renal cell carcinoma.
First Author: Michelle Hsu